In recent years, CGM technology was made for diabetes. It now attracts many non-diabetics. People want easier ways to improve their health. They use glucose monitors to check their body in real time. What deepens this change?
Understanding Continuous Glucose Monitoring
Traditional diabetes care required several finger pricks a day. New technology gives live glucose readings with a small sensor. The sensor stays just under the skin. It reads glucose from the fluid between cells. It sends data to a smartphone or pump by Bluetooth. Users see their blood sugar at any moment. They now manage their condition better.
A Booming Market
Over 37 million people in the U.S. have diabetes. That is about 11% of the population. Companies like Abbott and Dexcom fuel this market. Abbott’s Freestyle Libre and Dexcom’s monitors now earn billions in sales. In 2022, Abbott made $4.8 billion globally in diabetes care. Dexcom increased its revenue from $2.4 billion in 2021 to $2.9 billion in 2022. Yet, only about 7 million patients in the world use these devices. This gap leaves many possible users, non-diabetics included.
Shift in Focus
Firms that built CGMs for diabetes now reach out to all. Dexcom expanded its mission to care for health at large. Both Abbott and Dexcom still support diabetics. But they now see a place for health-focused individuals. Many non-diabetics use CGMs as a shield against future issues. They check glucose to learn how food and habits affect energy, weight, and well-being. Apps such as Levels make glucose tracking popular among fitness fans, dieters, and those curious about metabolism.
Why Non-Diabetics are Interested
- Preventative Health: People now guard their metabolic health. They watch for blood sugar spikes and dips. This helps them adjust their diet.
- Personalization of Health Management: Users get personal data. Knowing their glucose response aids them in choosing the right foods, boosting energy, and avoiding trouble.
- Data-Driven Insights: CGMs offer rich data. Users learn how stress, exercise, and sleep impact blood sugar.
- Integration with Technology: Health apps now include CGM data. Tech-savvy consumers enjoy a simple, joined view of their overall health.
Considerations and Challenges
CGMs still face some hurdles for non-diabetics. They often need a prescription. Insurance may not always cover them. Some users pay around $30 to $40 a month. Others may see higher costs without insurance help. The market is still growing. New tools like Abbott’s Lingo and non-invasive devices from tech giants such as Apple work in the lab or are available in small numbers.
Conclusion
Non-diabetics turning to glucose monitors mark a shift in health care. CGMs help people learn about their body functions in real time. These devices not only change diabetes care; they now form a part of many healthy lifestyles. As technology advances and choices grow, glucose monitoring may become a key tool for anyone committed to proactive health.
contact us @mindfulaimedia@gmail.com
No comments:
Post a Comment